Fu X - Search Results

1

A study on the treatment of rheumatoid arthritis with lipid nanoparticles containing mRNA encoding heat shock protein 10.

Liu Y, Shen H, Zang H, Shi Y, Qiu S, Fu X, Zhang Y, Chen X, Zhou J, Wan X, Lin G. Liu Y, et al. Among authors: fu x. J Pharm Sci. 2024 Dec 24:S0022-3549(24)00626-9. doi: 10.1016/j.xphs.2024.12.023. Online ahead of print. J Pharm Sci. 2024. PMID: 39725228

2

Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application.

Fu X, Shi Y, Gu Z, Zang H, Li L, Wang Q, Wang Y, Zhao X, Wu H, Qiu S, Zhang Y, Zhou J, Chen X, Shen H, Lin G. Fu X, et al. Asian J Pharm Sci. 2024 Jun;19(3):100925. doi: 10.1016/j.ajps.2024.100925. Epub 2024 May 3. Asian J Pharm Sci. 2024. PMID: 38966285 Free PMC article.

3

Multifunctional injectable microspheres for osteoarthritis therapy via spatiotemporally modulating macrophage polarization and inflammation.

Qiu S, Shi Y, Zang H, Sun X, Wang Q, Fu X, Shen H, Mo F, Zhang Y, Chen X, Zhou J, Li L, Lin G. Qiu S, et al. Among authors: fu x. NPJ Regen Med. 2024 Sep 17;9(1):22. doi: 10.1038/s41536-024-00368-w. NPJ Regen Med. 2024. PMID: 39289387 Free PMC article.

4

Preparation and release pattern study of long-term controlled release Blonanserin microspheres.

Chen X, Qiu S, Shi Y, Zang H, Li L, Fu X, Zhang Y, Zhou J, Liu Y, Wan X, Li Z, Li Y, Lin G. Chen X, et al. Among authors: fu x. Int J Pharm. 2024 Dec 5;666:124756. doi: 10.1016/j.ijpharm.2024.124756. Epub 2024 Sep 27. Int J Pharm. 2024. PMID: 39341383

5

Enzyme responsiveness enhances the specificity and effectiveness of nanoparticles for the treatment of B16F10 melanoma.

Huang Y, Shi Y, Wang Q, Qi T, Fu X, Gu Z, Zhang Y, Zhai G, Zhao X, Sun Q, Lin G. Huang Y, et al. Among authors: fu x. J Control Release. 2019 Dec 28;316:208-222. doi: 10.1016/j.jconrel.2019.10.052. Epub 2019 Nov 2. J Control Release. 2019. PMID: 31682909

6

Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment.

Fu X, Shi Y, Zang H, Wang Q, Wang Y, Wu H, Qiu S, Shen H, Mo F, Zhang Y, Lin G. Fu X, et al. J Control Release. 2022 Jul;347:1-13. doi: 10.1016/j.jconrel.2022.04.041. Epub 2022 May 4. J Control Release. 2022. PMID: 35508221

7

Relaxin-Loaded Inhaled Porous Microspheres Inhibit Idiopathic Pulmonary Fibrosis and Improve Pulmonary Function Post-Bleomycin Challenges.

Qiu S, Fu X, Shi Y, Zang H, Zhao Y, Qin Z, Lin G, Zhao X. Qiu S, et al. Among authors: fu x. Mol Pharm. 2023 Aug 7;20(8):3947-3959. doi: 10.1021/acs.molpharmaceut.3c00111. Epub 2023 Jun 26. Mol Pharm. 2023. PMID: 37358639

8

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Fu X, Shi Y, Qi T, Qiu S, Huang Y, Zhao X, Sun Q, Lin G. Fu X, et al. Signal Transduct Target Ther. 2020 Nov 6;5(1):262. doi: 10.1038/s41392-020-00342-0. Signal Transduct Target Ther. 2020. PMID: 33154350 Free PMC article. Review.

9

Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4.

Fu X, Shi Y, Wang H, Zhao X, Sun Q, Huang Y, Qi T, Lin G. Fu X, et al. Int J Nanomedicine. 2019 Nov 27;14:9275-9284. doi: 10.2147/IJN.S228863. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31819429 Free PMC article.

10

The role of antibody delivery formation in cancer therapy.

Qi T, Shi Y, Huang Y, Fu X, Qiu S, Sun Q, Lin G. Qi T, et al. Among authors: fu x. J Drug Target. 2020 Jul;28(6):574-584. doi: 10.1080/1061186X.2020.1728537. Epub 2020 Feb 18. J Drug Target. 2020. PMID: 32037905 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,671 results

Search Page

Filters